Detalles de la búsqueda
1.
Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC.
BMC Cancer
; 23(1): 69, 2023 Jan 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36670431
2.
Therapeutic strategies, oncologic and swallowing outcomes and their predictive factors in patients with locally advanced hypopharyngeal cancer.
Eur Arch Otorhinolaryngol
; 279(7): 3629-3637, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35076745
3.
Correlations between long-term quality of life and patient needs and concerns following head and neck cancer treatment and the impact of psychological distress. A multicentric cross-sectional study.
Eur Arch Otorhinolaryngol
; 278(7): 2437-2445, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32901366
4.
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 21(3): 446-455, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32078813
5.
Progressive Desmoid Tumor: Radiomics Compared With Conventional Response Criteria for Predicting Progression During Systemic Therapy-A Multicenter Study by the French Sarcoma Group.
AJR Am J Roentgenol
; 215(6): 1539-1548, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32991215
6.
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.
Lancet Oncol
; 20(1): 120-133, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477937
7.
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Lancet Oncol
; 20(9): 1263-1272, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31331699
8.
Evaluation of the information given to patients undergoing total pharyngolaryngectomy and quality of life: a prospective multicentric study.
Eur Arch Otorhinolaryngol
; 276(9): 2531-2539, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240456
9.
Radiotherapy for elderly patients and cetuximab, a monocentric study.
Eur Arch Otorhinolaryngol
; 274(2): 1061-1065, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27730326
10.
Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.
Eur Arch Otorhinolaryngol
; 274(1): 441-449, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27438536
11.
Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Eur Arch Otorhinolaryngol
; 273(10): 3299-306, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26858198
12.
Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
Eur Arch Otorhinolaryngol
; 273(9): 2681-7, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26395117
13.
Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas.
Genes Chromosomes Cancer
; 52(6): 580-90, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23508853
14.
Docetaxel-Cisplatin-Fluorouracil Induction Chemotherapy for Larynx Preservation in Patients with Locally Advanced Hypopharyngeal Cancer: Predictive Factors of Oncologic and Functional Outcomes.
J Clin Med
; 12(3)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769779
15.
Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors.
J Clin Med
; 12(4)2023 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36835841
16.
Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data.
Genes Chromosomes Cancer
; 50(6): 442-55, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21412931
17.
Population Pharmacokinetic Analysis of Pazopanib in Patients and Determination of Target AUC.
Pharmaceuticals (Basel)
; 14(9)2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34577627
18.
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Theranostics
; 11(19): 9571-9586, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34646387
19.
Incidence and prognostic factors of clinically meaningful toxicities of kinase inhibitors in older patients with cancer: The PreToxE study.
J Geriatr Oncol
; 12(4): 668-671, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32978101
20.
Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH).
Eur J Cancer
; 141: 21-29, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125944